Herausforderung Adhärenz bei der oralen Behandlung der CLL

• Literatur

• 1 Mansfield C, Masaquel A, Sutphin J. et al. Patients‘ priorities in selecting chronic lymphocytic leukemia treatments. Blood Adv 2017; 1 (24) 2176-2185
• 2 Zolnierek KBH, DiMatteo MR. et al. Physician communication and patient adherence to treatment: A meta-analysis. Med Care 2009; 47 (08) 826-834
• 3 Bender CM, Gentry AL, Brufsky AM. et al. Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer. Oncol Nurs Forum 2014; 41 (03) 274-285
• 4 Partridge AH, Wang PS, Winer EP. et al. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 2003; 21 (04) 602-606
• 5 Stanton AL. Determinants of adherence to medical regimens by hypertensive patients. J Behav Med 1987; 10 (04) 377-394
• 6 Krikorian S, Pories S, Tataronis S. et al. Adherence to oral chemotherapy: Challenges and opportunities. J Oncol Pharm Pract 2019; 25 (07) 1590-1598
• 7 Efficace F, Breccia M, Cottone F. et al. Psychological well-being and social support in chronic myeloid leukemia patients receiving lifelong targeted therapies. Support Care Cancer 2016; 24 (12) 4887-4894